V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004471 | 300003132 | 1.6 | 61.8 | Palliative (P) | 2017-11-04 | 2017-11-04 | ESPAC-4 TRIAL | 02 | N | 300023885 | FEC + DOCETAXEL |
| 300004472 | 300003132 | 1.69 | 77.6 | Neo-adjuvant (N) | 2013-07-09 | 2013-07-09 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 300023885 | CARBOPLATIN + RT |
| 300004473 | 300003133 | 1.65 | 80.5 | Adjuvant (A) | 2016-12-02 | 2016-12-04 | CISPLATIN + FLUOROURACIL + RT | N | N | 300023919 | HYDROXYCARBAMIDE |
| 300004474 | 300003134 | 1.64 | 41 | Not known (9) | 2014-08-05 | 2014-08-15 | Carboplatin AUC 6 - 10 | null | N | 300023925 | BEVACIZUMAB |
| 300004475 | 300003135 | 1.58 | 71 | Curative (C) | 2017-02-06 | 2017-02-06 | Capecitabine + Oxaliplatin 21day | 02 | N | 300023930 | EOX |
| 300004476 | 300003136 | 1.82 | null | Curative (C) | 2015-12-06 | 2015-12-13 | FLUOROURACIL + OXALIPLATIN | 02 | null | 300023931 | IMATINIB |
| 300004477 | 300003136 | 1.81 | 77.6 | null | 2017-03-02 | 2017-03-02 | CARBOPLATIN + FLUOROURACIL | 02 | null | 300023931 | CARBOPLATIN + ETOPOSIDE |
| 300004478 | 300003137 | 1.76 | 77.65 | Adjuvant (A) | 2014-07-19 | 2014-08-03 | DARS Trial | N | N | 300023938 | CISPLATIN + FLUOROURACIL + RT |
| 300004479 | 300003137 | 1.77 | 172.5 | null | 2016-08-27 | 2016-08-27 | Oxaliplatin + Raltitrexed | 02 | null | 300023938 | CARBOPLATIN + ETOPOSIDE |
| 300004480 | 300007466 | 1.57 | 53.8 | Adjuvant (A) | 2014-02-17 | 2014-02-24 | FLUOROURACIL + MITOMYCIN | N | N | 300023940 | BEVACIZUMAB |
| 300004483 | 300003140 | 1.78 | 66 | Curative (C) | 2016-04-04 | 2016-04-25 | Carboplatin AUC 6 - 10 | 02 | N | 300023954 | CAPECITABINE + RT |
| 300004484 | 300003141 | 1.58 | 73 | Curative (C) | 2014-04-15 | 2014-04-27 | FEC + DOCETAXEL | N | Y | 300023963 | HYDROXYCARBAMIDE |
| 300004485 | 300003142 | 1.69 | 73 | Curative (C) | 2013-10-24 | 2013-11-05 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | 300023964 | FEC |
| 300004486 | 300003143 | 1.55 | 61.8 | Curative (C) | 2008-06-29 | 2014-01-11 | Gemcitabine + Capecitabine | 2 | N | 300023966 | FLUOROURACIL + MITOMYCIN |
| 300004487 | 300003144 | 1.67 | 64.5 | Palliative (P) | 2017-05-17 | 2017-06-11 | CAPECITABINE + CISPLATIN + Trastuzumab | N | Y | 300023972 | FLUOROURACIL |
| 300004488 | 300003145 | 1.73 | 59.1 | null | 2013-12-19 | 2014-01-14 | Capecitabine 35days + RT | 02 | null | 300023975 | ESPAC TRIAL |
| 300004489 | 300003145 | 1.65 | 85.45 | Palliative (P) | 2013-04-10 | 2013-04-22 | Gemcitabine + Capecitabine | 01 | null | 300023975 | LENALIDOMIDE |
| 300004490 | 300003145 | 1.52 | 60.5 | Adjuvant (A) | 2016-03-10 | 2016-04-12 | PEMBROLIZUMAB | 02 | N | 300023975 | CARBOPLATIN + RT |
| 300004491 | 300003145 | 0 | null | Adjuvant (A) | 2014-11-30 | 2014-12-07 | CARBOPLATIN + RT | 2 | null | 300023975 | FLUOROURACIL + MITOMYCIN + RT |
| 300004492 | 300003146 | null | 63.2 | Palliative (P) | 2013-07-18 | 2014-03-26 | CAPECITABINE + OXALIPLATIN | N | N | 300024000 | BEVACIZUMAB |
| 300004493 | 300003146 | 1.69 | 53.8 | Curative (C) | 2013-08-06 | 2013-08-24 | CARBOPLATIN + ETOPOSIDE | N | Y | 300024000 | CARBO + FLUOROURACIL |
| 300004494 | 300003146 | 1.61 | 62 | Curative (C) | 2016-03-27 | 2016-04-08 | IDELALISIB | 01 | null | 300024000 | BEVACIZUMAB |
| 300004495 | 300003147 | null | 68 | Adjuvant (A) | 2016-03-12 | 2016-03-19 | Vemurafenib | 01 | N | 300024022 | CARBOPLATIN + ETOPOSIDE |
| 300004496 | 300003147 | 1.52 | 66.1 | Palliative (P) | 2017-12-12 | 2017-12-22 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 300024022 | FLUOROURACIL + MITOMYCIN |
| 300004499 | 300006134 | 1.73 | 81.1 | Palliative (P) | 2017-04-18 | 2017-05-07 | Carboplatin + Etoposide iv&po | null | null | 300024080 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004500 | 300006134 | null | 58.2 | Not known (9) | 2016-02-23 | 2016-03-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300024080 | CARBOPLATIN |
| 300004501 | 300003150 | 1.77 | 61.9 | Adjuvant (A) | 2013-12-05 | 2013-12-17 | Oxaliplatin + Modified de Gramont | N | N | 300024104 | CARBOPLATIN + RT |
| 300004502 | 300003151 | 1.6 | 36.5 | Palliative (P) | 2015-11-17 | 2015-12-01 | Etoposide + Ifosfamide (3 days) | 02 | N | 300024113 | ESPAC TRIAL |
| 300004503 | 300003152 | 1.67 | 88.9 | null | 2013-05-15 | 2013-05-16 | Carboplatin + Etoposide iv&po | 1 | N | 300024116 | FLUOROURACIL + MITOMYCIN |
| 300004504 | 300003153 | null | 57.4 | Curative (C) | 2017-07-07 | 2017-07-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | 01 | N | 300024119 | CAPECITABINE + MITOMYCIN + RT |
| 300004505 | 300003154 | 0 | 55.8 | Curative (C) | 2013-06-20 | 2013-06-29 | Bevacizumab 7.5mg/kg | 02 | Y | 300024122 | DE-ESCALATE TRIAL |
| 300004506 | 300003155 | 1.56 | 90 | Palliative (P) | 2013-11-12 | 2013-12-07 | FLUOROURACIL + MITOMYCIN | N | N | 300024124 | DABRAFENIB |
| 300004507 | 300003155 | 1.74 | 70.4 | Adjuvant (A) | 2013-11-25 | 2013-12-05 | Carboplatin AUC 2 - 5 | N | N | 300024124 | OXALIPLATIN + MDG |
| 300004508 | 300003155 | 1.67 | 30 | Palliative (P) | 2016-10-23 | 2016-12-03 | Capecitabine + Cisplatin | 2 | Y | 300024124 | CAPECITABINE + GEMCITABINE |
| 300004509 | 300003155 | 1.74 | 63.3 | Adjuvant (A) | 2014-12-11 | 2014-12-24 | ESPAC-4 TRIAL | Y | N | 300024124 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300004510 | 300003156 | 1.52 | 76.3 | Palliative (P) | 2016-06-26 | 2016-06-27 | Ipilimumab | 2 | N | 300024147 | IPILIMUMAB |
| 300004511 | 300003157 | 1.5 | 0 | null | 2015-05-20 | 2015-05-22 | IPILIMUMAB + NIVOLUMAB | N | Y | 300024149 | PCV |
| 300004512 | 300003158 | 1.84 | 97.6 | Curative (C) | 2016-03-07 | 2016-03-07 | Gemcitabine + Capecitabine | 2 | N | 300024152 | CISPLATIN + FLUOROURACIL + RT |
| 300004513 | 300003159 | 1.61 | null | Curative (C) | 2017-06-04 | 2017-06-24 | FLUOROURACIL + MITOMYCIN | 2 | N | 300024155 | CARBOPLATIN + RT |
| 300004514 | 300003159 | null | 143.3 | Palliative (P) | 2014-07-25 | 2014-08-05 | CARBOPLATIN + GEMCITABINE | N | N | 300024155 | CAPECITABINE + GEMCITABINE |
| 300004515 | 300003159 | 1.68 | 78.5 | Palliative (P) | 2016-01-19 | 2016-01-28 | CARBOPLATIN + RT | N | N | 300024155 | CARBOPLATIN |
| 300004516 | 300003159 | null | 90 | Adjuvant (A) | 2013-10-11 | 2013-10-12 | Gemcitabine + Capecitabine | 02 | N | 300024155 | CISPLATIN + FLUOROURACIL + RT |
| 300004517 | 300003160 | 1.63 | 110.25 | null | 2014-10-12 | 2014-10-25 | Folfirinox | null | null | 300024172 | GEMCARBO |
| 300004521 | 300003162 | 1.6 | null | Adjuvant (A) | 2016-02-07 | 2016-02-20 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300024201 | FLUOROURACIL + MITOMYCIN |
| 300004522 | 300003162 | 1.48 | 96 | Adjuvant (A) | 2013-11-04 | 2013-11-16 | Carboplatin AUC 6 - 10 | N | N | 300024201 | OXALIPLATIN + MDG |
| 300004524 | 300003164 | 1.49 | 65.2 | Palliative (P) | 2017-09-14 | 2017-09-14 | Ipilimumab | 2 | N | 300024208 | CAPECITABINE + OXALIPLATIN |
| 300004525 | 300003164 | 1.8 | 106.6 | Palliative (P) | 2017-03-25 | 2017-04-22 | Cisplatin+Fluorouracil+Streptozoc | 2 | N | 300024208 | CARBOPLATIN + ETOPOSIDE |
| 300004526 | 300003165 | 1.79 | null | Palliative (P) | 2016-04-20 | 2016-05-01 | GEMCITABINE + NAB PACLITAXEL | N | N | 300024219 | CAP + RT |
| 300004527 | 300003166 | 1.56 | 70 | Palliative (P) | 2013-12-30 | 2013-12-30 | Hydroxycarbamide | 02 | N | 300024228 | CISPLATIN + FLUOROURACIL + RT |
| 300004528 | 300003167 | 1.88 | 76 | Palliative (P) | null | 2016-04-11 | Capecitabine (21days) + Carboplatin | N | N | 300024230 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |